Assessment of Captopril and Nicardipine Effects on Chronic Occlusive Arterial Disease of the Lower Extremity Using Doppler Ultrasound

Angiology

Volumn 39, Issue 11, 1988, Pages 942-952

  Bernardi, Daniele ^a   Bartoli, Paolo ^a   Ferreri, Andrea ^a   Geri, Antonio Brandinelli ^a   Ieri, Aldo ^a  

^a Ospedale San Pietro Igneo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; NICARDIPINE;

CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; DOPPLER FLOWMETRY; HUMAN; LEG BLOOD FLOW; LEG ISCHEMIA; ORAL DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; CAPTOPRIL; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; EXERCISE TEST; HUMAN; INTERMITTENT CLAUDICATION; LEG; MALE; MIDDLE AGE; NICARDIPINE; RANDOM ALLOCATION; ULTRASONOGRAPHY;

EID: 0023692337     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/000331978803901103     Document Type: Article

References (40)

1. Juergens JL, Bernatz PE: Arteriosclerosis obliterans. In: Peripheral Vascular Diseases, ed. by Fairbairn JF, Juergens JL, Spittal JA Jr. Philadelphia, WB Saunders, 1979, pp 179-216.
2. Young JR: Diseases of the peripheral arteries. In: The Heart, ed. by Hurst JW. New York, McGraw-Hill, 1986, pp 1339-1346.
3. Dahn I., Ekman C., Lassen N., et al: On the conservative treatment of severe ischemia of the leg. Scand J Clin Lab Invest 19 (suppl 99):160-165, 1967.
4. Hertzer NR, Beven EG, Young JR: Coronary artery disease in peripheral vascular patients: A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199: 223-233, 1984.
5. Vidt DG, Bravo EL, Fouad F.: Captopril. N Engl J Med 306: 214-219, 1982.
6. Abrams WB, Davies RO, Ferguson RK: Overview: The role of angiotensin converting enzyme inhibitors in cardiovascular therapy. Fed Proc 43: 1314-1321, 1984.
7. Millard RW, Lathrop DA, Grupp G., et al: Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms. Am J Cardiol 49: 499-506, 1982.
8. Campbell BC, Kelman AW, Hillis W.: Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol 20: 55S-61S, 1985.
9. Longhini C., Musacci GF, Ansani L., et al: Peripheral hemodynamic response to angiotensin converting enzyme inhibitor single administration in hypertensive patients. Curr Ther Res 35: 707-713, 1984.
10. Simon A., Levenson J., Merli I.: Arteres et maladie hypertensive: intérêt de la inhibition calcique et expérience de la nicardipine. In: Nicardipine in Hypertension, ed. by Muiesan G, Rhodes, May 1-2, 1987, pp 32-39.
11. Clarke B., Grant D., Patmore L., et al: Comparative calcium entry blocking properties of nicardipine, nifedipine and PY 108068 on cardiac and vascular smooth muscle. Br J Pharmacol 79:333P, 1983.
12. Kempczinski RF, Rutherford RB: Current status of the vascular diagnostic laboratory. Adv Surg 12: 1-6, 1978.
13. Carter SA: Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med 287: 578-582, 1972.
14. Fronek A., Coel M., Bernstein EF: Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 53: 957-960, 1976.
15. Colton T.: Statistics in Medicine. Boston, Little, Brown and Company, 1974, pp 131-136.
16. Criqui M., Fronek A., Barrett-Connor E., et al: The prevalence of peripheral arterial disease in a defined population. Circulation 71: 510-515, 1985.
17. Skinner JS, Strandness DE Jr: Exercise and intermittent claudication. Circulation 36: 23-29, 1967.
18. Fronek A., Coel M., Bernstein DF: The importance of combined multisegmental pressure and Doppler flow velocity studies in the diagnosis of peripheral arterial occlusive disease. Surgery 84: 840-847, 1978.
19. Strandness DE Jr: Doppler methods for analysis of arterial and venous disorders. In: The Heart, ed. by Hurst JW. New York, McGraw-Hill, 1986, pp 1974-1977.
20. Dilley RB, Fronek A.: Quantitative velocity measurement in arterial disease of the lower extremity. In: Noninvasive Diagnostic Techniques in Vascular Disease, ed. by Bernstein EF. St. Louis, The CV Mosby Co, 1982, pp 350-359.
21. Strandness DE Jr: Exercise ankle pressure measurements in arterial disease. In: Noninvasive Diagnostic Techniques in Vascular Disease, ed. by Bernstein EF. St. Louis, The CV Mosby Co, 1982, pp 370-376.
22. Sharpe DN, Douglas JE, Coxon RJ, et al: Low-dose captopril in chronic heart failure: Acute haemodynamic effects and long-term treatment. Lancet ii: 1154-1157, 1980.
23. Forette F., Bellet M., Henry JF, et al: Effect of nicardipine in elderly hypertensive patients. Br J Clin Pharmacol 20: 125S-129S, 1985.
24. Shepherd J.: Circulation to skeletal muscle. In: Handbook of Physiology, ed. by Shepherd J, Abbound F, Geiger S. Bethesda, Md, American Physiological Society, 1983, pp 319-329.
25. MacGregor GA, Markandu ND, Roulson JE, et al: Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 291: 329-331, 1981.
26. Hatton R., Clough D., Faulkner K., et al: Angiotensin converting enzyme inhibitor resets baroceptor reflexes in conscious dogs. Hypertension 3: 676-681, 1981.
27. Laragh HJ: Conceptual diagnostic and therapeutic dimensions of renin-system profiling of hypertensive disorders and of congestive heart failure: Four new research frontiers. In: Hypertension and the Angiotensin System, ed. by Doyle AE, Beam AG. New York, Raven Press, 1983, pp 47-69.
28. Erne P., Bolli P., Bertel O., et al: Factors influencing the hypotensive effects of calcium antagonists. Hypertension 5 (suppl II):97-102, 1983.
29. Antignani PL, Amato B., De Fabritiis A., et al: Il Doppler ad Onda Continua. Torino, Centro Scientifico Torinese, 1985, pp 95-124.
30. Thulesius O.: Haemodynamic studies on experimental obstruction of the femoral artery in the cat. Acta Physiol Scand 67 (suppl 199):5-95, 1962.
31. Matsubara J.: Sympathetic innervation of the human leg arteries. Virchows Arch (Pathol Anat) 376: 343-351, 1977.
32. Agerskov K., Henriksen O., Tonnesen K., et al: Constriction of collateral arteries induced by ‘head-up tilt’ in patients with occlusive arterial disease of the legs. Cardiovasc Res 15: 675-679, 1981.
33. Kotchen TA, Hartley LH, Rice TW, et al: Renin, nor-epinephrine, and epinephrine responses to graded exercise. J Appl Physiol 31: 178-184, 1971.
34. Fagard R., Amery A., Reybrouck T.: Effectsof angiotensin antagonism on hemodynamics, renin, and catecholamines during exercise. J Appl Physiol 43: 440-444, 1977.
35. Fagard R., Lijnen P., Amery A.: Hemodynamic response to captopril at rest and during exercise in hypertensive patients. Am J Cardiol 49: 1569-1571, 1982.
36. Fagard R., Amery A., Reybrouck T.: Effects of antagonism at rest and during exercise in sodium depleted man. J Appl Physiol 44: 403-407, 1978.
37. Bellocci F., Ansalone G., Scabbia E., et al: Sustained beneficial effects of nifedipine in chronic refractory heart failure (Abstract). Am J Cardiol 47: 407, 1981.
38. Reit E.: Interaction of angiotensin with the autonomic nervous system. Fed Proc 31: 1331-1364, 1972.
39. McAubbin JW Peripheral effects of angiotensin on the autonomic nervous system. In: Angiotensin Handbook of Experimental Pharmacology, Vol. 37, ed. by Page IH, Bumpus FM. New York, Springer-Verlag, 1979, pp 417-423.
40. Antoniaccio MJ, Kerwin L.: Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive action of captopril. Hypertension 31: 54-62, 1981.